QuiVad

Home / Spain / Oryzon Genomics, S.A.

Oryzon Genomics, S.A.

Short position disclosed on July 3, 2026.

Follow

Funds holding Oryzon Genomics, S.A. Titelia

Evolution of the disclosed total

0%0.25%0.5%0.75%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 0.90% on April 28, 2026. The shaded band is the year shown above.

April 1, 2025 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Voleon Capital Management LP0.63%newJuly 3, 2026

History of disclosures

9 disclosures on record for this share.
DateFund% of capitalEnd of publication
July 3, 2026Voleon Capital Management LP0.63%still open
May 18, 2026Qube Research & Technologies Ltd0.00%still open
April 28, 2026Qube Research & Technologies Ltd0.90%still open
March 27, 2026Qube Research & Technologies Ltd0.80%still open
March 11, 2026Qube Research & Technologies Ltd0.72%still open
March 3, 2026Qube Research & Technologies Ltd0.63%still open
March 2, 2026Qube Research & Technologies Ltd0.55%still open
April 2, 2025Citadel Securities GCS (Ireland) Limited0.37%still open
April 1, 2025Citadel Securities GCS (Ireland) Limited0.58%still open

Other companies sold short in Spain

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oryzon Genomics, S.A., source CNMV, data as at July 3, 2026, https://www.quivad.com/action/oryzon-genomics-s-a